REPLIGEN RESPONDS TO COVID-19
May 27, 2020 Update:
Repligen understands and supports the vital role that our customers fill in the development and manufacture of biological drugs, vaccines and diagnostics. As a company, we are committed to employee health and safety, and to the continued supply of our products and services to our customers globally.
• Our manufacturing and distribution facilities are operational abiding by local and national regulations
• All products are available with stated lead times
• No raw material supply disruptions are anticipated
• Sales, Applications and Service support are available remotely, or in person if allowed